Press "Enter" to skip to content

France’s Sanofi to buy biotech firm Synthorx for $2.5 billion

Under the deal, Sanofi has offered to buy all the outstanding shares of Synthorx common stock for $68 per share in cash.

Original source: https://health.economictimes.indiatimes.com/news/pharma/frances-sanofi-to-buy-biotech-firm-synthorx-for-2-5-billion/72439054?utm_source=RSS&utm_medium=ETRSS

Also Read:   MSN Labs rolls out cheapest Covid-19 drug